BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 20225026)

  • 1. Phenotype and clinical evolution of Charcot-Marie-Tooth disease type 1A duplication.
    Berciano J; García A; Gallardo E; Ramón C; Combarros O
    Adv Exp Med Biol; 2009; 652():183-200. PubMed ID: 20225026
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Charcot-Marie-Tooth disease type 1A duplication with severe paresis of the proximal lower limb muscles: a long-term follow-up study.
    Berciano J; Gallardo E; García A; Infante J; Mateo I; Combarros O
    J Neurol Neurosurg Psychiatry; 2006 Oct; 77(10):1169-76. PubMed ID: 16788010
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical progression in Charcot-Marie-Tooth disease type 1A duplication: clinico-electrophysiological and MRI longitudinal study of a family.
    Berciano J; Gallardo E; García A; Ramón C; Infante J; Combarros O
    J Neurol; 2010 Oct; 257(10):1633-41. PubMed ID: 20443018
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Atypical presentation of Charcot-Marie-Tooth disease 1A: A case report.
    Kulkarni SD; Sayed R; Garg M; Patil VA
    Neuromuscul Disord; 2015 Nov; 25(11):916-9. PubMed ID: 26432165
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Atypical phenotype of charcot-marie-tooth disease type 1A.
    Murakami T; Oomori H; Hara A; Uyama E; Mita S; Uchino M
    Muscle Nerve; 1999 Nov; 22(11):1593-6. PubMed ID: 10514240
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Charcot-Marie-Tooth disease type 1A duplication: spectrum of clinical and magnetic resonance imaging features in leg and foot muscles.
    Gallardo E; García A; Combarros O; Berciano J
    Brain; 2006 Feb; 129(Pt 2):426-37. PubMed ID: 16317020
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Peripheral myelin protein 22 gene duplication with atypical presentations: a new example of the wide spectrum of Charcot-Marie-Tooth 1A disease.
    Mathis S; Corcia P; Tazir M; Camu W; Magdelaine C; Latour P; Biberon J; Guennoc AM; Richard L; Magy L; Funalot B; Vallat JM
    Neuromuscul Disord; 2014 Jun; 24(6):524-8. PubMed ID: 24792522
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neurophysiology and molecular genetics of Charcot-Marie-Tooth type 1 neuropathy in Croatian children: follow-up study.
    Barisić N; Mihatov I
    Croat Med J; 2000 Sep; 41(3):306-13. PubMed ID: 10962051
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A rat model of Charcot-Marie-Tooth disease 1A recapitulates disease variability and supplies biomarkers of axonal loss in patients.
    Fledrich R; Schlotter-Weigel B; Schnizer TJ; Wichert SP; Stassart RM; Meyer zu Hörste G; Klink A; Weiss BG; Haag U; Walter MC; Rautenstrauss B; Paulus W; Rossner MJ; Sereda MW
    Brain; 2012 Jan; 135(Pt 1):72-87. PubMed ID: 22189569
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phenotypic manifestations in French-Canadian populations with Charcot-Marie-Tooth disease type 1A associated with 17p11.2 duplication.
    Dupré N; Bouchard JP; Cossette L; Brunet D; Vanasse M; Lemieux B; Mathon G; Puymirat J
    Ann N Y Acad Sci; 1999 Sep; 883():497-9. PubMed ID: 10586283
    [No Abstract]   [Full Text] [Related]  

  • 11. Gene dosage is a mechanism for Charcot-Marie-Tooth disease type 1A.
    Lupski JR; Wise CA; Kuwano A; Pentao L; Parke JT; Glaze DG; Ledbetter DH; Greenberg F; Patel PI
    Nat Genet; 1992 Apr; 1(1):29-33. PubMed ID: 1301995
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patients homozygous for the 17p11.2 duplication in Charcot-Marie-Tooth type 1A disease.
    LeGuern E; Gouider R; Mabin D; Tardieu S; Birouk N; Parent P; Bouche P; Brice A
    Ann Neurol; 1997 Jan; 41(1):104-8. PubMed ID: 9005872
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New insights into the pathophysiology of pes cavus in Charcot-Marie-Tooth disease type 1A duplication.
    Berciano J; Gallardo E; García A; Pelayo-Negro AL; Infante J; Combarros O
    J Neurol; 2011 Sep; 258(9):1594-602. PubMed ID: 21590514
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Charcot-Marie-Tooth disease type 1A: molecular mechanisms of gene dosage and point mutation underlying a common inherited peripheral neuropathy.
    Roa BB; Garcia CA; Lupski JR
    Int J Neurol; 1991-1992; 25-26():97-107. PubMed ID: 11980069
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Congenital pes cavus in a Charcot-Marie-tooth disease type 1A newborn.
    Fusco C; Frattini D; Scarano A; Giustina ED
    Pediatr Neurol; 2009 Jun; 40(6):461-4. PubMed ID: 19433282
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Charcot-Marie-Tooth disease type 1A: a clinical, electrophysiological, pathological, and genetic study.
    Hsieh SY; Kuo HC; Chu CC; Lin KP; Huang CC
    Chang Gung Med J; 2004 Apr; 27(4):300-6. PubMed ID: 15239197
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Different clinical and magnetic resonance imaging features between Charcot-Marie-Tooth disease type 1A and 2A.
    Chung KW; Suh BC; Shy ME; Cho SY; Yoo JH; Park SW; Moon H; Park KD; Choi KG; Kim S; Kim SB; Shim DS; Kim SM; Sunwoo IN; Choi BO
    Neuromuscul Disord; 2008 Aug; 18(8):610-8. PubMed ID: 18602827
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Charcot-Marie-Tooth 1A: heterozygous T118M mutation over a CMT1A duplication has no influence on the phenotype.
    Seeman P; Mazanec R; Marikova T; Rautenstrauss B
    Ann N Y Acad Sci; 1999 Sep; 883():485-9. PubMed ID: 10586280
    [No Abstract]   [Full Text] [Related]  

  • 19. Duplication of the PMP22 gene in 17p partial trisomy patients with Charcot-Marie-Tooth type-1 neuropathy.
    Roa BB; Greenberg F; Gunaratne P; Sauer CM; Lubinsky MS; Kozma C; Meck JM; Magenis RE; Shaffer LG; Lupski JR
    Hum Genet; 1996 May; 97(5):642-9. PubMed ID: 8655146
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic epidemiology of Charcot-Marie-Tooth disease.
    Braathen GJ
    Acta Neurol Scand Suppl; 2012; (193):iv-22. PubMed ID: 23106488
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.